Drugs / LIFE-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06904807 | Apr 2025 → Nov 2026 expected | — | LifeMine Therapeutics | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LIFE-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06904807 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT06904807 ↗ |